Associate Professor, Hematology and Medical Oncology, Emory University School of Medicine
Oncology
Dr. Christopher R. Flowers, MD
|
|
Give Review
Christopher Flowers works in the field of Oncology. He went to medical school at Stanford University School of Medicine. Stanford University School of Medicine is a top medical university. Stanford University School of Medicine is ranked 2 in research and 25 in primary care medicine Christopher Flowers has written publications. He has 101 publications published with PubMed. The lastest publication is: 'Willingness-to-pay utility assessment: feasibility of use in normative patient decision support systems.'
Publications
- Effectiveness of first-line management strategies for stage I follicular lymphoma: Analysis of the National LymphoCare Study.
- Perspectives in Oncology Drug Pricing-Reply.
- Outcomes following watchful waiting for stage II-IV follicular Lymphoma patients in the modern era.
- A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell Lymphoma (DLBCL).
- Impact of Treatment and Insurance on Socioeconomic Disparities in Survival after Adolescent and Young Adult Hodgkin Lymphoma: A Population-Based Study.
- The genetic landscape of mutations in Burkitt Lymphoma.
- A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgki...
- Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer.
- Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.
- Venous thromboembolism prophylaxis and treatment in patients with Cancer: American Society of Clinical Oncology clinical practice guideline update.
- PI3Kdelta Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma.
- Comparing the Cost-Effectiveness of Rituximab Maintenance and Radioimmunotherapy Consolidation versus Observation Following First-Line Therapy in Patients with Follicu...
- Venous thromboembolism prophylaxis and treatment in patients with Cancer: american society of clinical oncology clinical practice guideline update 2014.
- Total Skin Electron Therapy for Cutaneous T-Cell Lymphoma Using a Modern Dual-Field Rotational Technique.
- Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell Lymphoma.
- First- and Second-Line Bevacizumab in Addition to Chemotherapy for Metastatic Colorectal Cancer: A United States-Based Cost-Effectiveness Analysis.
- American Cancer Society lung Cancer screening guidelines.
- Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular Lymphoma used in the United States.
- Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell Lymphoma.
- ACR Appropriateness Criteria Follow-up of Hodgkin Lymphoma.
- Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective Analysis.
- Medical History, Lifestyle, Family History, and Occupational Risk Factors for Diffuse Large B-Cell Lymphoma: The InterLymph Non-Hodgkin Lymphoma Subtypes Project.
- Medical History, Lifestyle, Family History, and Occupational Risk Factors for Follicular Lymphoma: The InterLymph Non-Hodgkin Lymphoma Subtypes Project.
- Medical History, Lifestyle, Family History, and Occupational Risk Factors for Peripheral T-Cell Lymphomas: The InterLymph Non-Hodgkin Lymphoma Subtypes Project.
- Etiologic Heterogeneity Among Non-Hodgkin Lymphoma Subtypes: The InterLymph Non-Hodgkin Lymphoma Subtypes Project.
- Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell Lymphoma.
- Pharmacoeconomic Analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation.
- Socioeconomic disparities in Lymphoma.
- The use and effectiveness of rituximab maintenance in patients with follicular Lymphoma diagnosed between 2004 and 2007 in the United States.
- ACR appropriateness criteria® pediatric hodgkin Lymphoma.
- Insurance status is related to diffuse large B-cell Lymphoma survival.
- Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy.
- Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin Lymphoma.
- Racial differences in chronic lymphocytic Leukemia. Digging deeper.
- Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic Cell transplants from partially mismatched unrelated donors.
- Racial differences in the presentation and outcomes of diffuse large B-cell Lymphoma in the United States.
- Renewed interest in the role of consolidative radiotherapy in advanced stage diffuse large B-cell Lymphoma.
- Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic Leukemia.
- Peripheral T-cell Lymphoma: what's the role for transplant?
- Temporal changes in plerixafor administration and hematopoietic stem Cell mobilization efficacy: results of a prospective clinical trial in multiple myeloma.
- Patterns of delivery of chemoimmunotherapy to patients with follicular Lymphoma in the United States: Results of the National LymphoCare Study.
- Bortezomib-containing induction regimens in transplant-eligible myeloma patients: A meta-Analysis of phase 3 randomized clinical trials.
- Lymphoma Occurring During Pregnancy: Antenatal Therapy, Complications, and Maternal Survival in a Multicenter Analysis.
- Communicating safe outpatient management of fever and Neutropenia.
- ACR Appropriateness Criteria: Localized nodal indolent Lymphoma.
- The role of chemotherapy in managing chronic lymphocytic Leukemia: optimizing combinations with targeted therapy.
- Residence proximity to benzene release sites is associated with increased incidence of non-Hodgkin Lymphoma.
- New Challenges in the Management of Diffuse Large B-Cell Lymphoma.
- Considerations in the initial management of follicular Lymphoma.
- Treatment Strategies for Patients with Diffuse Large B-Cell Lymphoma: Past, Present, and Future.
- Patterns of Failure in Advanced Stage Diffuse Large B-cell Lymphoma Patients After Complete Response to R-CHOP Immunochemotherapy and the Emerging Role of Consolidativ...
- Mobilization of Hematopoietic Progenitors from Normal Donors Using the Combination of Granulocyte-Macrophage Colony-Stimulating Factor and Granulocyte Colony-Stimulati...
- Examination of the follicular Lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predomin...
- Antimicrobial prophylaxis and outpatient management of Fever and Neutropenia in adults treated for malignancy: american society of clinical oncology clinical practice ...
- Examining racial differences in diffuse large B-cell Lymphoma presentation and survival.
- Management of relapsed chronic lymphocytic Leukemia: applying guidelines to practice.
- Using primary site as a predictor of survival in mantle cell Lymphoma.
- Genetic heterogeneity of diffuse large B-cell Lymphoma.
- Incidence and survival patterns of cutaneous T-cell Lymphomas in the United States.
- A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with Lymphoma.
- A systematic literature review and meta-Analysis of radioimmunotherapy consolidation for patients with untreated follicular lymphoma.
- Exploring risk factors for follicular Lymphoma.
- Initial management strategies for follicular Lymphoma.
- Racial differences in presentation and management of follicular non-Hodgkin Lymphoma in the United States: report from the National LymphoCare Study.
- Disparities in the Early Adoption of Chemoimmunotherapy for Diffuse Large B-cell Lymphoma in the United States.
- Characteristics and outcomes of diffuse large B-cell Lymphoma presenting in leukaemic phase.
- Pharmacokinetic-directed high-dose busulfan combined with cyclophosphamide and Etoposide results in predictable drug levels and durable long-term survival in Lymphoma ...
- Management Strategies for Elderly Patients with Diffuse Large B-Cell Lymphoma.
- Diffuse large B-cell Lymphoma: current treatment approaches.
- A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lym...
- Patterns of social support among Lymphoma patients considering stem cell transplantation.
- Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgk...
- Racial differences in the presentation and outcomes of chronic lymphocytic Leukemia and variants in the United States.
- Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma.
- Hepatitis C reactivation in patients who have diffuse large B-cell Lymphoma treated with rituximab: a case report and review of literature.
- Effectiveness and cost Analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics.
- A randomized clinical trial comparing granulocyte-colony-stimulating factor administration sites for mobilization of peripheral blood stem Cells for patients with hema...
- Clinical, molecular, and environmental risk factors for hodgkin Lymphoma.
- Incidence patterns and outcomes for hodgkin Lymphoma patients in the United States.
- Tipifarnib sensitizes Cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes.
- A decade of progress in Lymphoma: advances and continuing challenges.
- Receiver operating characteristic curve Analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patien...
- Improving outcomes for patients with diffuse large B-cell Lymphoma.
- A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple Myeloma: a dose- and schedule-finding study.
- Surveillance computed tomography scans for patients with Lymphoma: is the risk worth the benefits?
- Improving our use and understanding of antibodies in B-cell Lymphomas.
- Multicenter randomized phase II study of weekly or twice-weekly bortezomib plus rituximab in patients with relapsed or refractory follicular or marginal-zone B-Cell ly...
- Follicular Lymphoma in the United States: first report of the national LymphoCare study.
- Posttransplant thrombopoiesis predicts survival in patients undergoing autologous hematopoietic progenitor Cell transplantation.
- Racial variation in coloRectal polyp and tumor location.
- Racial differences in the incidence and outcomes for patients with hematological malignancies.
- Treatment of relapsed Acute leukemia after allogeneic transplantation: a single center experience.
- Refractory or relapsed Hodgkin's disease and non-Hodgkin's Lymphoma: optimizing involved-field radiotherapy in transplant patients.
- Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic Cell transplantation from HLA-matched related donors.
- Comparing the cost-effectiveness of the triple test score to traditional methods for evaluating palpable breast masses.
- Prophylactic cholecystectomy in transplant patients: a decision Analysis.
- Schizophrenia, monoamine oxidase activity, and cigarette smoking.
- Willingness-to-pay utility assessment: feasibility of use in normative patient decision support Systems.
- American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with Cancer.
- Genetically predicted longer telomere length is associated with increased risk of B-cell Lymphoma subtypes.
Schools
Stanford University
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Choice HMO
- Blue Choice Option POS
- Blue Open Access POS
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Golden Rule
- GEHA
- Choice Care PPO
- Preferred PPO
- Kaiser Permanente
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
University of Washington -
Stanford University School of Medicine
Hospital
-
Emory University Hospital -
Emory University Hospital Midtown -
Grady Memorial Hospital
Drug Facts
| NPI NUMBER | 1174630503 | |
| NPPES Provider LastName | FLOWERS | |
| NPPES Provider FirstName | CHRISTOPHER | |
| NPPES Provider ZIPCode | 303221013 | |
| NPPES Provider State | GA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 412.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 33.0 | |
| Percent Opioid Claims | 8.01 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1174630503 |
| Last Name Of The Provider | FLOWERS |
| First Name Of The Provider | CHRISTOPHER |
| View All |
Similar Doctors
|
|
Dr. Sanford H. Schwartz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nabil F. Saba, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vinita Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard S. Leff, MD |
|
|
Dr. Donald J. Filip, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Omer Kucuk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Salahattin M. Sanal, MD |
|
|
Dr. Rathi N. Pillai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel R. Newcom, MD |
|
|
Dr. Mamoru Shoji, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth P. Weinzierl, MD |